New drug aims to tame brain swelling after bleeding stroke

NCT ID NCT05020535

Ongoing Disease control Sponsor: Johns Hopkins University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests an experimental drug called MW189 in 120 adults who have had a brain bleed (intracerebral hemorrhage). The goal is to see if the drug is safe and can reduce brain swelling. Participants receive the drug within 24 hours of their stroke and are monitored for side effects and survival.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INTRACEREBRAL HEMORRHAGE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

brain edema intracerebral hemorrhage Neuroinflammatory Diseases

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INTRACEREBRAL HEMORRHAGE

Contacts and locations

Locations

Cleveland Clinic Florida

Stuart, Florida, 34994, United States
Johns Hopkins Hospital

Baltimore, Maryland, 21287, United States
New York University Grossman School of Medicine

Brooklyn, New York, 11220, United States
Stanford University

Palo Alto, California, 94304, United States
University of Alabama Birmingham

Birmingham, Alabama, 35294, United States
University of Cincinnati

Cincinnati, Ohio, 45219, United States
University of Kentucky

Lexington, Kentucky, 40536, United States
University of New Mexico

Albuquerque, New Mexico, 87131, United States
University of Texas Houston

Houston, Texas, 77030, United States
University of Texas San Antonio

San Antonio, Texas, 78229, United States
Yale New Haven Hospital

New Haven, Connecticut, 06511, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.